Transgene Biotek has inked pact with Atral Cipan of Portugal by signing Tacrolimus Licensing and Technology Transfer agreement. As per the agreement, Atral Cipan will move the products through regular filings with the USFDA and European Medicines Agency (EMEA) for manufacturing and marketing Tacrolimus.
Both companies believe that Transgene’s experience and skills in developing technologies, coupled with the global presence and pharmaceutical experience of Atral Cipan, will expand the commercialization and marketing of Tacrolimus across several developed markets including the US and Europe.
| Company Name | CMP |
|---|---|
| Syngene Internation. | 435.70 |
| Indegene | 486.80 |
| CMS Info Systems | 318.00 |
| JITF Infralogistics | 338.00 |
| Sagility | 42.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: